Small molecules showing significant protection of mice against botulinum neurotoxin serotype A.
Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism that could afflict large, unprotected populations if the toxin were employed in an act of bioterrorism. Current post-exposure therapy is limited to symptomatic treatment or passive immunization that is effective for treating infant botulism at a cost of US $45,300 per treatment regimen. Antibodies can neutralize the extracellular but not the intracellular BoNTA. Moreover, antibody production, storage, and administration in a mass casualty scenario pose logistical challenges. Alternatively, small-molecule inhibitors of BoNTA endopeptidase (BoNTAe) are sought to antagonize the extracellular or intracellular toxin. While several such molecules reportedly demonstrated efficacy in protecting cells against BoNTA, there is scant information to show that small molecules can significantly protect mammals against BoNTA. Herein we report the development of effective small-molecules BoNTAe inhibitors with promising in vivo pharmacokinetics. One such molecule has an in vivo half-life of 6.5 hours and is devoid of obvious sign of toxicity. Pre-treatment with this molecule at 2 mg/kg protected 100% and 70% of treated mice against BoNTA at 5 times of its median-lethal dose during the periods of 2 and 4 half-lives of the inhibitor, respectively. In contrast, 40% and 0% of untreated mice survived during the respective periods. Similar levels of protection were also observed with two other small molecules. These results demonstrate that small molecules can significantly protect mice against BoNTA and support the pursuit of small-molecule antagonists as a cost-effective alternative or as an adjunct to passive immunity for treating botulism.
Pang
Yuan-Ping
YP
Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America. pang@mayo.edu
Davis
Jon
J
Wang
Shaohua
S
Park
Jewn Giew
JG
Nambiar
Madhusoodana P
MP
Schmidt
James J
JJ
Millard
Charles B
CB
D000818:Animals; D023482:Bioterrorism; D019274:Botulinum Toxins, Type A / Q000037:antagonists & inhibitors*; D003365:Costs and Cost Analysis; D051379:Mice; D009498:Neurotoxins; D011480:Protease Inhibitors / Q000191:economics / Q000493:pharmacokinetics* / Q000627:therapeutic use; D020011:Protective Agents; D015996:Survival Rate
D009498:Neurotoxins; D011480:Protease Inhibitors; D020011:Protective Agents; D019274:Botulinum Toxins, Type A
J Infect Dis. 1984 Sep;150(3):407-12
6481185
Toxicon. 2010 Apr 1;55(4):818-26
20003913
Am J Law Med. 2006;32(2-3):279-323
16927613
Clin Neuropharmacol. 2007 Sep-Oct;30(5):310-3
17909312
PLoS One. 2007 Aug 22;2(8):e761
17712409
JAMA. 2001 Feb 28;285(8):1059-70
11209178
Biophys J. 2009 Aug 5;97(3):853-6
19651043
Proteins. 2006 Nov 15;65(3):712-25
16981200
Ann Intern Med. 1998 Aug 1;129(3):221-8
9696731
J Biol Chem. 2007 Feb 16;282(7):5004-5014
17092934
Bioorg Med Chem. 2006 Jan 15;14(2):395-408
16203152
J Comput Chem. 2005 Dec;26(16):1668-88
16200636
Proteins. 2001 Nov 15;45(3):183-9
11599021
PLoS One. 2009 Nov 10;4(11):e7730
19901994
Biochemistry. 2008 May 27;47(21):5736-45
18457419
Bioorg Med Chem. 2009 Apr 15;17(8):3072-9
19329331
Protein Sci. 2000 Oct;9(10):1857-65
11106157
J Clin Immunol. 1993 Mar;13(2):145-51
8320311
Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9984-9
15985558
FEBS Lett. 1998 Sep 11;435(1):61-4
9755859
J Chem Theory Comput. 2007 Nov;3(6):2312-34
26636222
Neurotoxicology. 1997;18(3):761-70
9339823
Chem Biol Drug Des. 2008 Feb;71(2):131-9
18221310
Pediatrics. 2007 Apr;119(4):785-9
17403850
Chem Commun (Camb). 2006 Aug 7;(29):3063-5
16855686
Antimicrob Agents Chemother. 2009 Aug;53(8):3478-86
19528275
JAMA. 1997 Aug 6;278(5):399-411
9244332
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2602-7
17293454
JAMA. 2009 Jun 10;301(22):2316
19509371
Nature. 2004 Dec 16;432(7019):925-9
15592454
J Protein Chem. 1997 Jan;16(1):19-26
9055204
Science. 2007 Sep 28;317(5846):1881-6
17901324
Pharmacol Rev. 1981 Sep;33(3):155-88
6119708
J Biol Chem. 2003 Jan 10;278(2):1363-71
12381720